logo
Select company
Select metric
38.95Enterprise Value over EBIT
VS
Market
20
Sector
22
Industry
22
History
38
$ 6.06Close
$ 3.53 - $ 7.6 52-Week Range
Ticker Information

Ticker

ICCC

Company Name

IMMUCELL CORP

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

IMMUCELL CORP - Enterprise Value over EBIT Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

ICCC - EV/EBIT Historical data
DateEarning Before Interest & Taxes (EBIT)Enterprise ValueEnterprise Value over EBIT
6/30/2025$ 1.77M$ 69.05M38.95
3/31/2025$ -261.16K$ 54.43M0
12/31/2024$ -2.15M$ 56.34M0
9/30/2024$ -3.81M$ 43.18M0
6/30/2024$ -4.05M$ 43.97M0
3/31/2024$ -3.89M$ 58.09M0
12/31/2023$ -5.77M$ 56.09M0
9/30/2023$ -6.3M$ 55M0
6/30/2023$ -6.01M$ 52.53M0
3/31/2023$ -5.31M$ 48.55M0
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Definition of Enterprise Value over EBIT

[Calculation] Measures a company’s Enterprise Value [EV] in relation to its earnings before interest and taxes [EBIT].
EV / EBIT
(=) EV/EBIT
EV/EBIT for IMMUCELL CORP is calculated as follows: EV [ $ 46.62M ] / EBIT [ $ -1.54M ]
(=) EV/EBIT [ 0 ]

ICCC - Enterprise Value over EBIT, Last 5 years

38.95

Minimum

Jun 30, 2025

1.46K

Maximum

Sep 30, 2021

447.33

Average

147.59

Median

EV/EBIT Benchmark Analysis

The chart above depicts the distribution of EV/EBIT for companies in the Total Stock Market. The average EV/EBIT of the companies is 19.91 with a standard deviation of 12.32.
The following table provides additional summary stats:
EV/EBIT in the Market:
filtered constituents2.25K
min0.05
max62.03
average19.91
median16.78
std12.32